CONCORD DRUGS
Back to Income Statement
|
CONCORD DRUGS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Adjusted EPS | ₹0.34 | ₹0.47 | ₹1.06 | ₹1.82 |
What is the latest Earnings Per Share (EPS) of CONCORD DRUGS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹0.34 |
| Mar2024 | ₹0.47 |
| Mar2023 | ₹1.06 |
| Mar2022 | ₹1.82 |
How is Earnings Per Share (EPS) of CONCORD DRUGS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.34 | -27.66 | |
| Mar2024 | ₹0.47 | -55.66 | |
| Mar2023 | ₹1.06 | -41.76 | |
| Mar2022 | ₹1.82 | - | |
Compare Earnings Per Share (EPS) of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹93.7 Cr | -2.6% | -0.5% | 34.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -2.6% |
-0.5% |
34.8% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses